eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-COGT-Cogent Biosciences Inc

Cogent Biosciences Inc COGT

$13.050.11(0.85%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in Cogent Biosciences Inc
Today
Create an eToro account to buy COGT stock on a secure, user-friendly, multi-asset trading platform.
Buy Cogent Biosciences Inc
Buy Cogent Biosciences Inc
Cogent Biosciences Inc COGT
Buy COGT
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Strong Buy
Price Target
21.50
Based on analysts who covered COGT

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Cogent Biosciences Inc News

About Cogent Biosciences Inc
Cogent Biosciences Inc. is a biotechnology company that develops novel precision therapies to treat a wide range of unmet medical needs. Operating on a global scale, the company is committed to improving the lives of patients by discovering therapies for genetically defined diseases.

Based in the biotechnology industry, Cogent Biosciences Inc. works with a network of research scientists to provide research, development, and production of medical therapies. The company’s pipeline product portfolio focuses on bezuclastinib, a highly selective and potent KIT inhibitor with the potential to provide solutions for patients fighting genetically driven diseases.

Diversify your virtual portfolio by following COGT shares on eToro.
VIEW MORE   

COGT Stock Price Chart

‎11.16‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Cogent Biosciences Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Cogent Biosciences Inc price today is $13.05, a ‎0.85‎% change in the last 24 hours and ‎8.03‎% in the past week. Cogent Biosciences Inc price changed by ‎19.29‎% in the past year.
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
-
Day’s Range
i
Shows the high and low prices of the day.
$12.74 - $13.13
52W Range
i
Shows the high and low prices of the last year.
$3.87 - $13.45
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
-
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-
Revenue
i
The total income generated by this company’s goods and services last year.
-
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
-
Prev Close
i
The final price of this asset at the end of the last trading day.
$13.05
EPS
i
A company’s total earnings divided by the number of shares it has issued.
-
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
-
What Is Cogent Biosciences Inc?
Cogent Biosciences Inc. is a biotechnology company that develops novel precision therapies to treat a wide range of unmet medical needs. Operating on a global scale, the company is committed to improving the lives of patients by discovering therapies for genetically defined diseases.

Based in the biotechnology industry, Cogent Biosciences Inc. works with a network of research scientists to provide research, development, and production of medical therapies. The company’s pipeline product portfolio focuses on bezuclastinib, a highly selective and potent KIT inhibitor with the potential to provide solutions for patients fighting genetically driven diseases.

Diversify your virtual portfolio by following COGT shares on eToro.
CEO
Andrew R. Robbins, MBA
Employees
205
Founded
2014
HQ
Waltham, Massachusetts, US
Med Tech
NASDAQ
Buy COGT

How can I buy Cogent Biosciences Inc stocks?

To purchase Cogent Biosciences Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Cogent Biosciences Inc (COGT) page and place an order to buy Cogent Biosciences Inc.
Buy COGT
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy Cogent Biosciences Inc
Invest in Cogent Biosciences Inc
Today
Create an eToro account to buy COGT stock on a secure, user-friendly, multi-asset trading platform.
Buy COGT

FAQ

The current price of COGT is $13.05.
The average price target for Cogent Biosciences Inc is $21.50. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Cogent Biosciences Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Cogent Biosciences Inc is -
Based on 5 analysts offering recommendations for COGT in the last 3 months, the overall consensus is Strong Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top